These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8046978)

  • 21. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala.
    Smiałowska M; Bajkowska M; Heilig M; Obuchowicz E; Turchan J; Maj M; Przewłocki R
    Neuropeptides; 2001 Apr; 35(2):82-91. PubMed ID: 11384203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin 5-HT(2C) receptors regulate anxiety-like behavior.
    Heisler LK; Zhou L; Bajwa P; Hsu J; Tecott LH
    Genes Brain Behav; 2007 Jul; 6(5):491-6. PubMed ID: 17451451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons.
    Spiga F; Lightman SL; Shekhar A; Lowry CA
    Neuroscience; 2006; 138(4):1265-76. PubMed ID: 16488545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of placental neurohormones in human parturition.
    Petraglia F; Coukos G; Volpe A; Genazzani AR; Vale W
    Ann N Y Acad Sci; 1991; 622():331-40. PubMed ID: 2064193
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
    Kokare DM; Dandekar MP; Chopde CT; Subhedar N
    Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestrogenic regulation of pro-opiomelanocortin, neuropeptide Y and corticotrophin-releasing hormone mRNAs in mouse hypothalamus.
    Pelletier G; Li S; Luu-The V; Labrie F
    J Neuroendocrinol; 2007 Jun; 19(6):426-31. PubMed ID: 17388940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y immunoreactivity and corticotropin-releasing hormone mRNA level are increased in the hypothalamus of mouse bearing a human oral squamous cell carcinoma.
    Lee JH; Cha MJ; Choi SH; Hwang SJ; Kim DG; Jahng JW
    Neuropeptides; 2004 Dec; 38(6):345-50. PubMed ID: 15567470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y.
    Inui A; Okita M; Nakajima M; Momose K; Ueno N; Teranishi A; Miura M; Hirosue Y; Sano K; Sato M; Watanabe M; Sakai T; Watanabe T; Ishida K; Silver J; Baba S; Kasuga M
    Proc Assoc Am Physicians; 1998; 110(3):171-82. PubMed ID: 9625524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent insights into body weight control: from physiology to pathology.
    Krysiak R; Okopień B; Belowski D; Madej A; Herman ZS
    J Pept Sci; 2001 Nov; 7(11):571-8. PubMed ID: 11763361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of the endocannabinoid system with neuropeptide Y and corticotropin-releasing factor in the goldfish forebrain.
    Cottone E; Guastalla A; Pomatto V; Campantico E; Palermo F; Magni AM; Mackie K; Franzoni MF
    Ann N Y Acad Sci; 2009 Apr; 1163():372-5. PubMed ID: 19456363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the role of neuropeptides in depression and anxiety.
    Rana T; Behl T; Sehgal A; Singh S; Sharma N; Abdeen A; Ibrahim SF; Mani V; Iqbal MS; Bhatia S; Abdel Daim MM; Bungau S
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 114():110478. PubMed ID: 34801611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
    Todorovic C; Jahn O; Tezval H; Hippel C; Spiess J
    Neurosci Biobehav Rev; 2005; 29(8):1323-33. PubMed ID: 16099044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of CRF but not NPY in the anxiety regulation via NMDA receptors.
    Wierońska JM; Szewczyk B; Pałucha A; Brański P; Smiałowska M
    Pol J Pharmacol; 2003; 55(6):1119-24. PubMed ID: 14730109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced neuropeptide Y mRNA expression in the central nucleus of amygdala of alcohol preferring (P) rats: its potential involvement in alcohol preference and anxiety.
    Suzuki R; Lumeng L; McBride WJ; Li TK; Hwang BH
    Brain Res; 2004 Jul; 1014(1-2):251-4. PubMed ID: 15213011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of corticotropin-releasing factor, neuropeptide Y and corticosterone in the regulation of food intake in Xenopus laevis.
    Crespi EJ; Vaudry H; Denver RJ
    J Neuroendocrinol; 2004 Mar; 16(3):279-88. PubMed ID: 15049859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of neuropeptide Y in anxiety].
    Krysiak R; Obuchowicz E; Herman ZS
    Psychiatr Pol; 2001; 35(5):731-42. PubMed ID: 11842605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal dexamethasone exposure affects anxiety-like behaviour and neuroendocrine systems in an age-dependent manner.
    Nagano M; Ozawa H; Suzuki H
    Neurosci Res; 2008 Apr; 60(4):364-71. PubMed ID: 18243386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine and behavioral effects of neuromedin S.
    Jászberényi M; Bagosi Z; Thurzó B; Földesi I; Telegdy G
    Horm Behav; 2007 Dec; 52(5):631-9. PubMed ID: 17900576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat.
    Compère V; Li S; Leprince J; Tonon MC; Vaudry H; Pelletier G
    Brain Res Mol Brain Res; 2005 Nov; 141(2):156-60. PubMed ID: 16154662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuropeptides in Alzheimer's disease].
    Jiménez-Corral C; Morán-Sánchez JC; Alonso-Navarro H
    Rev Neurol; 2006 Mar 16-31; 42(6):354-9. PubMed ID: 16575772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.